Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Frassoni

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.
Leukemia & Lymphoma|March 1, 1996
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapyA M Carella, E Prencipe, E Pungolino, et al.
Bone Marrow Transplantation|February 18, 1998
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experienceT Lamparelli, M T Van Lint, F Gualandi, et al.
Bone Marrow Transplantation|February 27, 2007
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow TransplantationM A Sanz, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation|February 6, 2007
Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcomeA Bacigalupo, T Lamparelli, F Gualandi, et al.
Blood|February 25, 1999
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemiaA M Carella, E Lerma, M T Corsetti, et al.
Bone Marrow Transplantation|February 1, 1996
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemiaA M Carella, F Chimirri, M Podestà, et al.
Blood|August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCTJ W van Esser, B van der Holt, E Meijer, et al.
Bone Marrow Transplantation|July 10, 2012
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMTS Giebel, M Labopin, M Mohty, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.
Leukemia & Lymphoma|March 1, 1996
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapyA M Carella, E Prencipe, E Pungolino, et al.
Bone Marrow Transplantation|February 18, 1998
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experienceT Lamparelli, M T Van Lint, F Gualandi, et al.
Bone Marrow Transplantation|February 27, 2007
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow TransplantationM A Sanz, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation|February 6, 2007
Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcomeA Bacigalupo, T Lamparelli, F Gualandi, et al.
Blood|February 25, 1999
Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemiaA M Carella, E Lerma, M T Corsetti, et al.
Bone Marrow Transplantation|February 1, 1996
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemiaA M Carella, F Chimirri, M Podestà, et al.
Blood|August 9, 2001
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCTJ W van Esser, B van der Holt, E Meijer, et al.
Bone Marrow Transplantation|July 10, 2012
The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMTS Giebel, M Labopin, M Mohty, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
Pageof 22